Insights

webinar

Presented by Pete Michels, Ph.D., Head of Global Fermentation, Curia Jose Luis Barredo, Ph.D., Director, Engineering Services, Curia Listen in as our experts discuss: A brief history of biocatalysis with a look at its current and futur...

webinar

Presented by Mark Wolf, Ph.D., Section Head, Medicinal Chemistry - Curia Doug Kitchen, Ph.D., Section Head, CADD, Medicinal Chemistry - Curia Listen in as our experts discuss: The importance of a strong hit-to-lead program in drug d...

webinar

Presented by Brian Haney, Ph.D., Director of Technical Operations, Curia Iain MacGilp, Ph.D., Director, GMP Production, Curia Listen in as our experts discuss: The basics of handling HPAPI's safely in GMP production settings The trad...

white paper

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...

webinar

Presenters: Ankit Agrawal, Senior Director, Commercial Strategy, Curia Anish Parikh, Vice President, Drug Product Sales & Marketing, Curia Listen in as our experts discuss: The shortage of sterile manufacturing capacity within CDMOs given...

webinar

Presenters: Peter Talbiersky, Ph.D., Manager of Fine Chemicals Sales, Curia Listen in as our experts discuss: The importance of a green and versatile condensation reagent Safe alternative for commonly used condensation reagents like dicyclohe...

webinar

Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function th...

article

Though synthetic biology may be regarded as a new or emerging field of science, the concept of applying biological systems to improve chemical synthesis goes back hundreds — arguably, thousands — of years. From the earliest fermentation processes...

article

As part of our deep commitment to diversity and inclusion in the workplace, Curia is very proud to be participating in the two-year Mansfield Rule: Legal Department Edition (MRLD) initiative.

webinar

In vitro biochemical assays make possible the high throughput screening (HTS) of large compound libraries. A successful HTS campaign is typically viewed as one that identifies large numbers of diverse chemical series hits as potential starting points...

article

CDMOs that routinely handle highly potent compounds must raise the bar for containment, safety, and industrial hygiene. Diverse capabilities across chemistries, purification technologies, and analytical techniques — combined with the ability to sup...

article

It is no coincidence that the booms in prefilled syringes (PFS) and biologic medicines are happening at the same time – the two are intrinsically linked. Innovative biologic medicines demand innovative delivery systems to match, and as the utility...